STARCZEWSKI, Łukasz et al. Clinical Efficacy, Mechanism of Action, and Adverse Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes – a Systematic Review. Quality in Sport, [S. l.], v. 54, 2026. DOI: 10.12775/QS.2026.54.70481. Disponível em: https://apcz.umk.pl/QS/article/view/70481. Acesso em: 21 apr. 2026.